Updates in Treatment and Management Approaches for Hormone-Sensitive Prostate Cancer

Updates in Treatment and Management Approaches for Hormone-Sensitive Prostate Cancer is organized by Specialty Pharma Education Center (SPEC).

Available Until: 3/15/2022

Learning Objectives:
After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Oncology Pharmacists, Oncology Nurses and Nurses
• Discuss the incidence of hormone-sensitive prostate cancer
• Recognize the clinical characteristics of hormone-sensitive prostate cancer
• Describe evidence-based approaches to optimizing care for patients with oligometastatic hormone-sensitive prostate cancer
• Discuss evidence-based management of patients with polymetastatic hormone-sensitive prostate cancer
• Review clinical data evaluating novel and emerging agents in patients with hormone-sensitive prostate cancer
• Describe the importance of post-treatment supportive care